Microbix Biosystems Inc. (TSX:MBX)

Market Cap	42.46M +21.7%
Revenue (ttm)	15.40M -27.1%
Net Income	-4.88M
EPS	-0.04
Shares Out	136.97M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	6,400
Open	0.2950
Previous Close	0.3100
Day's Range	0.2950 - 0.3100
52-Week Range	0.2100 - 0.3250
Beta	0.54
Analysts	n/a
Price Target	n/a
Est. Earnings	Dec 18, 2026

About Microbix Biosystems

Microbix Biosystems Inc., a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. The company manufactures a wide range of critical biological materials and medical devices for the global diagnostics industry, notably test ingredients (Antigen business) used in immunoassays, quality assessment, and diagnostic-test products, such as test-controls under the QAPs brand; viral transport medium for enabling the collection of p...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1988
• Employees: 70
• Stock Exchange: Toronto Stock Exchange
• Ticker Symbol: MBX

Financial Performance

Data Sources: S&P Global Market Intelligence and QUODD

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by QUODD.

Last checked:

Oct 9, 2026

Data Sources Report a data error